Presentation THT 2026 Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study Presenter: Ryan J. Tedford March 03, 2026
Presentation THT 2026 Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension Presenter: Yogesh Reddy March 02, 2026
Presentation THT 2026 3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients Presenter: Ryan J. Tedford March 02, 2026
Partner Content The Real Impact of Paradise™ Ultrasound RDN: Real Data. Real Durability. Real Difference January 22, 2026